Inovalon and OMNY Health Link Real-World Data to Boost Therapeutic Research — Inovalon Holdings, Inc.

Event summary

Inovalon and OMNY Health launched a linked real-world dataset combining Inovalon’s closed claims data with OMNY Health’s EHR data and clinical notes.
The dataset includes 248 million lives in closed claims, 175 million lives in EHR data, and 7+ billion clinical notes, with over 40% of lives linked across sources.
Inovalon made an undisclosed strategic investment in OMNY Health as part of the collaboration.
The partnership aims to accelerate research and improve patient outcomes by providing a comprehensive view of disease progression and treatment patterns.

The big picture

This partnership addresses the growing need for comprehensive, real-world data in healthcare research. By combining longitudinal claims data with clinical depth from EHRs and notes, Inovalon and OMNY Health aim to bridge gaps in understanding disease progression and treatment outcomes. The collaboration underscores a broader industry shift toward leveraging advanced analytics and AI to accelerate therapeutic innovation.

What we're watching

Data Integration Impact: How the integration of claims and EHR data will affect the speed and accuracy of therapeutic research.
Market Adoption: Whether life sciences organizations will widely adopt this linked dataset for real-world evidence studies.
Competitive Dynamics: The pace at which competitors respond with similar data integration solutions.